Rossiane Claudia Vommaro

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biofísica Carlos Chagas Filho

Departamento:

Programa de Biologia Celular e Parasitária/Biof

ORCID:

https://orcid.org/0000-0003-4768-1555


Formação:

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 1997 - 1997

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 1991 - 1996

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas | Especialização | 1988 - 1988

  • Universidade Federal do Rio de Janeiro

    Ciencias Biológicas | Graduação | 1985 - 1988

  • Colégio Pedro II- São Cristóvao

    | Ensino Médio (2o grau) | 1982 - 1984
Laboratórios:
Nuvens de Palavras:
Artigos:

(93.10% artigos com DOI)

Titulo DOI Ano
An alternative method to establish an early acute ocular toxoplasmosis model for experimental tests 10.1007/s10792-024-02985-2 2024
Potent hydroxamate-derived compounds arrest endodyogeny of Toxoplasma gondii tachyzoites 10.1016/j.exppara.2024.108727 2024
Intracellular life of protozoan Toxoplasma gondii: parasitophorous vacuole establishment and survival strategies 10.32604/biocell.2023.026629 2023
P2X7 receptor modulation of the gut microbiota and the inflammasome determines the severity of Toxoplasma gondii-induced ileitis 10.3390/biomedicines11020555 2023
Binding of the extracellular matrix laminin-1 to Clostridioides difficile strains 10.1590/0074-02760220035 2022
Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis 10.1128/msphere.01002-20 2021
Characterization of an emergent high-risk KPC-producing Klebsiella pneumoniae lineage causing a fatal wound infection after spine surgery 10.1016/j.meegid.2021.105122 2021
The life-cycle of Toxoplasma gondii reviewed using animations 10.1186/s13071-020-04445-z 2020
HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics 10.1016/j.ijpddr.2020.12.003 2020
Disruption of P2X7 Signaling Increases Susceptibility to Cerebral Toxoplasmosis 10.1016/j.ajpath.2019.01.001 2019
Identification of the alpha-enolase P46 in the extracellular membrane vesicles of Bacteroides fragilis 10.1590/0074-02760170340 2018
Tu1784 - The Severity of Murine Toxoplasma Gondii -Induced Crohn'slike Ileitis is Modulated by P2X7 Signaling 10.1016/s0016-5085(18)33410-3 2018
Assay to Access Anthelmintic Activity of Small Molecule Drugs Using Caenohabidtis elegans as a Model 10.21769/BioProtoc.2113 2017
Toxoplasma gondii reorganizes the host cell architecture during spontaneous cyst formation in vitro 10.1017/s0031182017002050 2017
Inflammatory early events associated to the role of P2X7 receptor in acute murine toxoplasmosis 10.1016/j.imbio.2016.12.007 2017
The P2X7 Receptor Mediates Toxoplasma gondii Control in Macrophages through Canonical NLRP3 Inflammasome Activation and Reactive Oxygen Species Production 10.3389/fimmu.2017.01257 2017
A Glycosylphosphatidylinositol-Anchored Carbonic Anhydrase-Related Protein of Toxoplasma gondii Is Important for Rhoptry Biogenesis and Virulence 10.1128/msphere.00027-17 2017
Anthelmintic effect of herbicidal dinitroanilines on the nematode model Caenorhabditis elegans 10.1016/j.exppara.2016.04.017 2016
Apicoplast fatty acid synthesis is essential for pellicle formation at the end of cytokinesis in Toxoplasma gondii 10.1242/jcs.185223 2016
Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo 10.1016/j.micinf.2015.09.016 2016
Ciprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondii 10.1371/journal.pone.0125705 2015
<i>Bacteroides fragilis</i> Supernatant Extracts Enriched in Phenylacetic Acid Induce a Cytotoxic Effect in Mammalian Cells 10.4236/aim.2015.510077 2015
Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages 10.1371/journal.pone.0133502 2015
Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis 10.1007/s00436-013-3715-6 2014
Toxoplasma gondii: The effect of Fluconazole combined with Sulfadiazine and Pyrimethamine against acute toxoplasmosis in murine model 10.1016/j.exppara.2012.12.011 2013
Caenorhabditis elegans as a model for the screening of anthelminthic compounds: Ultrastructural study of the effects of albendazole 10.1016/j.exppara.2013.05.011 2013
Inactivation of a fibronectin-binding TonB-dependent protein increases adhesion properties of Bacteroides fragilis 10.1099/jmm.0.054692-0 2013
Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii 10.1016/j.parint.2012.12.003 2013
Divergent synthesis of 2,6-diaryl-substituted 5,7,8-trimethyl-1,4-benzoxazines via microwave-promoted palladium-catalyzed Suzuki¿Miyaura cross coupling and biological evaluation 10.1016/j.tet.2012.10.009 2012
CONSIDERAÇÕES ATUAIS SOBRE A BIOLOGIA DO Toxoplasma gondii E SUA INTERAÇÃO COM A CÉLULA HOSPEDEIRA 2011
Evaluation of three novel azasterols against Toxoplasma gondii 10.1016/j.vetpar.2010.11.034 2011
Ester prodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies 10.1039/c1md00022e 2011
The organization of the wall filaments and characterization of the matrix structures of Toxoplasma gondii cyst form 10.1111/j.1462-5822.2011.01681.x 2011
Organização Estrutural da Forma Taquizoíta de Toxoplasma gondii 2010
Toxoplasma gondii: Fluconazole and itraconazole activity against toxoplasmosis in a murine model 10.1016/j.exppara.2009.12.011 2010
Induction of cell death on Plasmodium falciparum asexual blood stages by Solanum nudum steroids 10.1016/j.parint.2010.02.002 2010
Activation of the P2X7 receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages 10.1016/j.micinf.2010.03.004 2010
New details on the fine structure of the rhoptry of Toxoplasma gondii 10.1002/jemt.20960 2010
The fine structure of the 10.1111/j.1574-6968.2010.01925.x 2010
Toxoplasma gondii: further studies on the subpellicular network 10.1590/S0074-02762009000500007 2009
Bacteroides fragilis induce necrosis on mice peritoneal macrophages: In vitro and in vivo assays 10.1016/j.bbrc.2009.05.124 2009
Thiolactomycin analogues as potential anti-Toxoplasma gondii agents 10.1016/j.parint.2009.08.004 2009
Freeze-fracture study of the dynamics of Toxoplasma gondii parasitophorous vacuole development 10.1016/j.micron.2007.01.002 2008
Itraconazole affects Toxoplasma gondii endodyogeny 10.1111/j.1574-6968.2008.01130.x 2008
The redox potential interferes with the expression of laminin binding molecules in Bacteroides fragilis 10.1590/S0074-02762008000700010 2008
Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro 10.1093/jac/dkl180 2006
Bacteroides fragilis interferes with iNOS activity and leads to pore formation in macrophage surface 10.1016/j.bbrc.2004.11.085 2005
Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii 10.1016/j.ijantimicag.2004.08.016 2005
Intravacuolar network may act as a mechanical support forToxoplasma gondii inside the parasitophorous vacuole 10.1002/jemt.20182 2005
Antiproliferative effects of azasterols on Toxoplasma gondii 2005
Selective anti-Toxoplasma gondii activities of azasterols 10.1016/j.ijantimicag.2003.11.005 2004
Cultured Embryonic Retina Systems as a Model for the Study of Underlying Mechanisms of Toxoplasma gondii Infection 10.1167/iovs.04-0177 2004
Bacteroides fragilis adherence to Caco-2 cells 10.1016/S1075-9964(03)00008-8 2002
Surface charge and surface carbohydrates of cryptobia salmositica virulent and avirulent forms and of C. bullocki (Kinetoplastida: Cryptobiidae) 10.1007/s004360050322 1997
Computer Aided Three-dimensional Reconstruction of the Free living Protozoan Bodo sp. (Kinetoplastida: Bodonidae). 10.1247/csf.21.297 1996
Freeze-fracture study ofBodo sp. (Kinetoplastida: Bodonidae) 10.1002/jemt.1070300305 1995
The cell surface charge of Bodo sp. (Kinetoplastida: Bodonidae) 10.1016/s0932-4739(11)80294-4 1993
Comparative Study Of The Surface Charge Of Some Isolates Of Trypanosomatids Of The Genus Phytomonas 1989
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
The fluoroquinolone besifloxacin is active against Toxoplasma gondii proliferation in vitro 2023
The role of P2X7 receptor during acute infection with EGS strain. 2023
TEM used to investigate the effects of new lysine deacetylase inhibitors as an alternative for the treatment of acute ocular toxoplasmosis 2023
Novel histone deacetylase inhibitors as an alternative for the treatment of toxoplasmosis - in vitro analysis 2022
Effect of histone deacetylase inhibitors as an alternative for the treatment of ocular toxoplasmosis 2022
P2X7 Receptor Participating in Intestinal Infection Control in Mice Infected with T. gondii ? EGS Strain 2022
P2X7 receptor-mediated autophagy in the control of Toxoplasma gondii infection 2022
The Use of 2-hydroxyethyl methacrylate Resin for Histopathology Analysis in the Ocular Toxoplasmosis Model 2021
Super-Resolution Structured Illumination Microscopy for Analysis of New Chemotherapeutics Against Toxoplasma gondii 2021
Participation of P2X7R-mediated autophagy in the control of Toxoplasma gondii infection. 2021
Analysis of the Effect of Histone Deacetylase Inhibitors against Toxoplasma gondii using Super-Resolution Structured Illumination Microscopy 2019
Effect of P2X7 Activation in Human Monocyte Cells Infected By Toxoplasma gondii - EGS Strain 2019
Study of the effects of histone deacetylase inhibitors on Toxoplasma gondii 2019
EVALUATION OF VIRULENCE FACTORS BY PATHOGENIC LEPTOSPIRA SPP. ISOLATED FROM HUMAN CASES OF LEPTOSPIROSIS 2019
Contribution of P2X7 receptor during Toxoplasma gondii induced gut inflammation 2018
HISTONE DEACETYLASE INHIBITORS AS A NOVEL APPROACH FOR THE TREATMENT OF TOXOPLASMOSIS 2017
CHARACTERIZATION OF THE EXTRACELLULAR VESICLES OF TOXOPLASMA GONDI 2017
P2X7 Receptor Control Toxoplasma gondii Infection Through ROS from NADPH-oxidase 2017
MORPHOLOGICAL ANALYSIS OF APICOPLAST FASII DISRUPTION IN THE PARASITE Toxoplasma gondii BY FLUORESCENCE AND ELECTRON MICROSCOPY 2016
Toxoplasma gondi cytokinesis completion is dependent on apicoplast type II fatty acid biosynthesis 2016
COMPARISON OF THREE TOXOPLASMA GONDII STRAINS INTERACTION WITH CENTRAL NERVOUS SYSTEM CELLS 2016
HOST CELL REORGANIZATION IN TOXOPLASMA GONDII CHRONIC INFECTION ANALYSED BY CONFOCAL AND TRANSMISSION ELECTRON MICROSCOPY 2016
Mitochondrial ROS: its importance in the elimination of T. gondii due activation of P2X7 receptor 2016
NADPH-Oxidase is the Mein Souce of ROS Induced by P2X7 Receptor Activation in Toxoplasma gondii Infected Macrophage 2016
Development of stage specific fluorescent strains of Toxoplasma 2015
Apicoplast fatty acid synthesis is essential for Toxoplasma gondii division process 2015
A glycosylphosphatidylinositol (GPI)-anchored carbonic anhydraserelated protein (CA-RP) localizes to the rhoptries of Toxoplasma gondii and is important for virulence 2015
Ultrastructural Aspects of Cyst Wall Formation During Conversion of Toxoplasma gondii 2015
APICOPLAST FATTY ACID SYNTHESIS IS ESSENTIAL FOR TOXOPLASMA GONDII DIVISION 2015
HOST CELL REORGANIZATION UNDER TOXOPLASMA GONDII CYST FORMATION 2015
EXTRACELLULAR VESICLES SECRETED BY TOXOPLASMA GONDII 2015
CONVERSION OF TOXOPLASMA GONDII BRADYZOITES INTO TACHYZOITES IN INTESTINAL CELLS 2014
DEVELOPMENT OF A DOUBLE FLUORESCENT MUTANT STRAIN OF TOXOPLASMA GONDII TO FOLLOW CYST FORMATION IN VITRO AND IN VIVO. 2014
Evaluation of host cell modifications under cyst formation 2013
Ciprofloxacin Derivatives are Potential New Treatment for Toxoplasmosis 2013
Triclosan treatment arrests Toxoplasma gondii division and apicoplast morphology and division 2013
Spontaneous cystogenesis of EGS strain in different cell types 2013
Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii 2012
Effect of ciprofloxacin derivatives against Toxoplasma gondii in vitro. 2012
Triclosan affects toxoplasma gondii division and apicoplast morphology 2012
The association of fluconazole and antifolates as a promising chemotherapy against toxoplasmosis 2011
Effect of ciprofloxacin derivatives against Toxoplasma gondii 2011
THE EFFECT OF P2Y RECEPTORS IN TOXOPLASMA GONDII-INFECTED MACROPHAGES 2011
Extracellular ATP against Toxoplasma gondii: The involvement of P2X7 receptor in the pathogen spread contention 2011
Pyrimethamine-loded lipid core nanocapsules to improve the grug delivery for the treatment of toxoplasmosis 2011
The surface of the rhoptry of Toxoplasma gondii by freeze-fracture and quick-freeze/deep-etching technique 2010
The structure of the cyst wall of Acanthamoeba polyphaga by quick-freeze/deep-etching technique 2010
Caracterização in Vitro dos Componentes do Cisto em Formação de Toxoplasma gondii 2010
Effects of Albendazole on the ultrastructure of the experimental model Caenorhabditis elegans 2010
Effect of Itraconazole against tissue cysts of Toxoplasma gondii in vitro and in vivo 2010
The Structure of Toxoplasma gondii Cyst by Quick-freeze/Deep-etch Technique 2009
The involvement of the P2x7 receptor in immune response against Toxoplasma gondii infection 2009
O envolvimento do receptor P2X7 na resposta contra toxoplasma gondii: estudo in vitro e in vivo 2009
Speculations on the motility of the conoid of Toxoplasma gondii based on ultrastructural data 2009
Characterization of the components of the cyst matrix of Toxoplasma gondii 2009
1,4 -Benzoxazine analogues arrest To'xoplasma gondii proliferation in vitro 2009
Freeze-fracture And Quick-freeze/Deep-etching Of The Rhoptries Of Toxoplasma Gondii 2009
FURTHER STUDIES ON THE ULTRASTRUCTURE OF TOXOPLASMA GONDII CYSTS 2008
NEW ASPECTS OF THE ULTRASTRUCTURE OF TOXOPLASMA GONDII CYSTS 2008
Toxoplasma gondii infection modulated by extracellular ATP 2008
THE AZOLES ITRACONAZOLE AND FLUCONAZOLE AS PROMISING DRUGS AGAINST TOXOPLASMOSIS 2008
FATTY ACID BIOSYNTHESIS INHIBITORS THIOLACTOMYCINS AS POTENTIAL ANTI-TOXOPLASMA GONDII AGENTS 2008
Interference of the transcriptional regulator OxyR and catalase in Bacteroides fragilis survival within peritoneal macrophages 2008
P2X7 receptors activation modulates toxoplasma gondii clearance in infected macrophages 2008
T.gondii infection modulated by extracellular ATP 2008
Azasterols arrest Toxoplasma gondii proliferation in vitro 2007
MODE OF ACTION OF THE ANTIFUNGIC ITRACONAZOLE AGAINST TOXOPLASMA GONDII TACHYZOITES IN CELL CULTURE 2007
ITRACONAZOLE AFFECTS THE ULTRASTRUCTURE AND ENDODYOGENY OF TOXOPLASMA GONDII 2007
Ultrastructural characterization of isolated cysts of Toxoplasma gondii 2007
Fatty acid biosynthesis inhibitors thiolactomycins as potential anti-Toxoplasma gondii agents. 2007
NEW INSIGHTS ON TOXOPLASMA GONDII RHOPTRIES 2007
Análise dos efeitos da interação das espécies Bacteroides vulgatus e Bacteroides thetaiotaomicron com macrófagos peritoniais de camundongos 2007
Effect of P2X7 receptor activation on Toxoplasma gondii-infected macrophages 2007
MULTIPLE APPROACHES IN THE STUDY OF THE ULTRASTRUCTURE OF THE CONOID OF Toxoplasma gondii 2007
Ultrastructural Study of the Effects of Steroids of Solanum nudum on uninfected and Plasmodium falciparum infected erythrocytes 2007
Effects of steroids of Solanum nudum in normal and infected -Plasmodium falciparum erythrocytes 2006
Effect of itraconazole on the ultrastructure and endodiogeny of Toxoplasma gondii. 2006
Bacteroides fragilis strains express an apoptosis inducer factor in different cultured cells lineages (Vero and peritoneal macrophages) 2006
Bacteroides fragilis induce necrosis on mice peritoneal macrophages: in vitro and in vivo assays 2006
Antifungicid itraconazole has anti Toxoplasma gondii activity in vitro and in vivo 2006
A view over Toxoplasma gondii isolated cysts 2006
Two novel squalene synthase inhibitors arrest Toxoplasma gondii prloiferation in vivo. 2005
Estudo dos sistemas de neurotransmissores durante a infecção da retina pelo Toxoplasma gondii 2005
Cepas de Bacteroides fragilis induzem o processo de necrose em macrófagos peritoneais de camundongo 2005
Fator termo-resistente de cepas de Bacteroides fragilis induz intumescimento miticondrial levando a apoptose de células Vero 2005
Azasterols Arrest Toxoplasma gondii Proliferation Causing Severe Mitochondrial Damage 2004
Activity of poliamines and retinal cell culture infected by Toxoplasma gondii 2004
Proteins of the family of articulins are present in the subpellicular network of Toxoplasma gondii. 2004
Ultrastructure of Toxoplasma gondii treated with ergosterol biosynthesis inhibitors 2003
Synergism between sterol biosynthesis inhibitor with the current treatment for human toxoplasmosis. 2003
Alterações morfológicas em macrófagos peritoniais de camundongos infectados com cepas de Bacteroides fragilis e análise da produção de NO nestes macrófagos 2003
Bacteroides fragilis culture supernatants induce a vacuolation phenotype on Vero cells. 2003
Correlação entre atividade da ornitina descarboxilase e a proliferação do Toxoplasma gondii em culturas de células retinianas 2003
Morphological alterations in mice peritoneal macrophages infected with Bacteroides fragilis strains and analysis of NO production in these macrophages 2003
Influence of CPC expression in Bacteroides fragilis adhesion to peritoneal macrophages and interference of the infection in iNOS distribution. 2003
Interferência do potencial redox na expressão de fatores de virulência de Bacteroides fragilis 2003
Freeze fracture Analysis of the Parasitophorous Vacuole Membrane during Toxoplasma gondii infection 2002
STUDY OF THE PARASITOPHOROUS VACUOLE OF TOXOPLASMA GONDII BY FREEZE FRACTURE ANALYSIS 2002
Effect of Ergosterol Biosynthesis Inhibitors on Toxoplasma gondii 2002
Análise do Vacúolo Parasitóforo no Processo de Infecção do Toxoplasma gondii em Células Epiteliais através de Criofratura 2002
Inhibitors of D 24(25) sterol methyltransferase block sterol sinthesis and cell proliferation in Toxoplasma gondii. 2001
The relationship between the expression of Bacteroides fragilis surface structures and its adhesion to Caco ?2 Cells 2001
TOXOPLASMA GONDII ENTRY INTO MDCK EPITHELIAL CELLS WITH TRANSFECTED RHO GTPASE PROTEINS 2000
OVEREXPRESSION OF GFAP GENE PROMOTER IN MURINE ASTROCYTES INFECTED BY TOXOPLASMA GONDII IN THE PRESENCE OF IFN ANF TNF 2000
Further Studies On The Cell Surface Of Cryptobia Salmositica (Virulentand Avirulent Strains). 1996
Cryptobia Bullocki Cell Surface 1995
Ultrastructural Analysis Of Bodo Sp. By Deep Etching Technique 1995
Observation Of Cytoskeleton Of Detergent Extracted Cells Of Bodo Sp By Transmission And High Resolution Electron Microscopy 1995
Serial Section-Based, And Computer Aided E-Dimentional Reconstruction Of The Free Living Protozoan Bodo Sp. (Kinetoplastida: Bodonidae) 1995
3-D Reconstruction Of Bodo Sp. 1994
Study Of The Cell Surface Of Cryptobia Bullocki (Kinetoplastida: Cryptobiida 1994
Study Of The Cell Surface Of Cryptobia Bullocki (Kinetoplastida: Cryptobiida) 1993
Freeze-Fracture Analysis Of Cryptobia Bullocki (Kinetoplastida: Cryptobiida) 1993
Study Of The Cell Surface Of Bodo Sp. (Kinetoplastida: Bodonidae) 1992
A Freeze-Fracture Study Of Bodo Sp. 1992
Cytochemical Analysis Of Bodo Sp (Kinetoplastid: Bodonidae) 1991
Ultrastructural Cytochemistry Approach To The Surface Charge Of The Genus Bodo Sp. 1991
Surface Charge Of Isolates Of The Genus Bodo Sp. 1990
Lectin Binding Sites In Bodo Sp. 1989
Uso da Ferritina Cationizada e Ferro Coloidal No Estudo Comparativo de Superficie de 4 Isolados do Genero Phytomonas 1988
Comparative Study Of The Surface Charge Of Some Isolates Of Trypanosomatids Of The Genus Phytomonas 1988
Ultraestrutura de Bodo Sp. Isolado de Cocus Nucifera 1988
Publicações:
Minha Rede: